Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: CrCest Study in Primary Mitochondrial Disease

View source ↗

Summary

The CrCest Study for primary mitochondrial disease is currently enrolling by invitation, indicating an ongoing clinical research effort with no results yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Mitochondrial Diseases | Status: ENROLLING_BY_INVITATION